1. Home
  2. KREF vs TECX Comparison

KREF vs TECX Comparison

Compare KREF & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Real Estate Finance Trust Inc.

KREF

KKR Real Estate Finance Trust Inc.

N/A

Current Price

$5.40

Market Cap

337.4M

Sector

Real Estate

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$20.45

Market Cap

371.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KREF
TECX
Founded
2014
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
337.4M
371.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
KREF
TECX
Price
$5.40
$20.45
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$7.00
★ $71.00
AVG Volume (30 Days)
★ 924.6K
159.4K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 7.46%
N/A
EPS Growth
N/A
★ 40.70
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$349.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.94
$16.77
52 Week High
$9.11
$39.53

Technical Indicators

Market Signals
Indicator
KREF
TECX
Relative Strength Index (RSI) 41.39 43.37
Support Level $5.09 $18.54
Resistance Level $6.01 $23.03
Average True Range (ATR) 0.34 1.25
MACD 0.02 0.36
Stochastic Oscillator 42.60 46.07

Price Performance

Historical Comparison
KREF
TECX

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: